Gender-Specific Metabolomic Profiling of Obesity in Leptin-Deficient ob/ob Mice by 1H NMR Spectroscopy

PLoS ONE

Volumn 8, Issue 10, 2013, Pages

  Won, Eun Young ^a,b   Yoon, Mi Kyung ^a   Kim, Sang Woo ^a   Jung, Youngae ^c   Bae, Hyun Whee ^c,d   Lee, Daeyoup ^b   Park, Sung Goo ^a   Lee, Chul Ho ^a   Hwang, Geum Sook ^c,d   Chi, Seung Wook ^a  

^a Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^b Korea Advanced Institute of Science and Technology (KAIST)   (South Korea)

^c Korea Basic Science Institute (KBSI)   (South Korea)

^d Chungnam National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

2 HYDROXYISOBUTYRATE; 2 PROPANOL; ACETOACETIC ACID; ACETONE; ALANINE; ARGININE; BIOLOGICAL MARKER; CARNITINE; CHOLESTEROL; CHOLINE; CITRIC ACID; CREATININE; GLYCOLIC ACID; HIPPURIC ACID; HYDROXYBUTYRIC ACID; ISOBUTYRIC ACID; LEUCINE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LYSINE; METHIONINE; METHYLAMINE; ORNITHINE; PARA CRESOL; PYRUVIC ACID; TAURINE; TRIGONELLINE; TRIMETHYLAMINE OXIDE; UNCLASSIFIED DRUG; UREA; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

AMINO ACID METABOLISM; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD SAMPLING; CREATINE METABOLISM; FEMALE; GLUCOSE METABOLISM; GLYCOLYSIS; GUT MICROBIOME DERIVED METABOLISM; LIPID METABOLISM; MALE; METABOLISM; METABOLOMICS; MOUSE; NONHUMAN; OBESITY; PHOSPHOLIPID SYNTHESIS; PROTON NUCLEAR MAGNETIC RESONANCE; SEX DIFFERENCE; SPHINGOLIPID METABOLISM; STEROIDOGENESIS; URINALYSIS;

ANIMALS; BIOLOGICAL MARKERS; FEMALE; LEPTIN; MAGNETIC RESONANCE SPECTROSCOPY; MALE; METABOLOMICS; MICE; MICE, OBESE; MULTIVARIATE ANALYSIS; OBESITY; SEX CHARACTERISTICS;

EID: 84884852924     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0075998     Document Type: Article

References (83)

1. WHO website, Available: http://www.who.int/features/factfiles/obesity/en/.Accessed 2013 Aug 27.
2. Conway B, Rene A, (2004) Obesity as a disease: no lightweight matter. Obes Rev 5: 145-151.
3. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, et al. (1994) Positional cloning of the mouse obese gene and its human homologue. Nature 372: 425-432.
4. Friedman JM, Halaas JL, (1998) Leptin and the regulation of body weight in mammals. Nature 395: 763-770.
5. Zhang F, Basinski MB, Beals JM, Briggs SL, Churgay LM, et al. (1997) Crystal structure of the obese protein leptin-E100. Nature 387: 206-209.
6. Montague CT, Farooqi IS, Whitehead JP, Soos MA, Rau H, et al. (1997) Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature 387: 903-908.
7. Strobel A, Issad T, Camoin L, Ozata M, Strosberg AD, (1998) A leptin missense mutation associated with hypogonadism and morbid obesity. Nat Genet 18: 213-215.
8. Fischer-Posovszky P, von Schnurbein J, Moepps B, Lahr G, Strauss G, et al. (2010) A new missense mutation in the leptin gene causes mild obesity and hypogonadism without affecting T cell responsiveness. J Clin Endocrinol Metab 95: 2836-2840.
9. Clement K, Vaisse C, Lahlou N, Cabrol S, Pelloux V, et al. (1998) A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction. Nature 392: 398-401.
10. Farooqi IS, Matarese G, Lord GM, Keogh JM, Lawrence E, et al. (2002) Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency. J Clin Invest 110: 1093-1103.
11. Nicholson JK, Lindon JC, (2008) Systems biology: Metabonomics. Nature 455: 1054-1056.
12. Connor SC, Hansen MK, Corner A, Smith RF, Ryan TE, (2010) Integration of metabolomics and transcriptomics data to aid biomarker discovery in type 2 diabetes. Mol Biosyst 6: 909-921.
13. Spratlin JL, Serkova NJ, Eckhardt SG, (2009) Clinical applications of metabolomics in oncology: a review. Clin Cancer Res 15: 431-440.
14. Martin FP, Wang Y, Sprenger N, Yap IK, Lundstedt T, et al. (2008) Probiotic modulation of symbiotic gut microbial-host metabolic interactions in a humanized microbiome mouse model. Mol Syst Biol 4: 157.
15. Serkova NJ, Jackman M, Brown JL, Liu T, Hirose R, et al. (2006) Metabolic profiling of livers and blood from obese Zucker rats. J Hepatol 44: 956-962.
16. Waldram A, Holmes E, Wang Y, Rantalainen M, Wilson ID, et al. (2009) Top-down systems biology modeling of host metabotype-microbiome associations in obese rodents. J Proteome Res 8: 2361-2375.
17. Zhao LC, Zhang XD, Liao SX, Gao HC, Wang HY, et al. (2010) A metabonomic comparison of urinary changes in Zucker and GK rats. J Biomed Biotechnol 2010: 431894.
18. Schirra HJ, Anderson CG, Wilson WJ, Kerr L, Craik DJ, et al. (2008) Altered metabolism of growth hormone receptor mutant mice: a combined NMR metabonomics and microarray study. PLoS One 3: e2764.
19. Duggan GE, Hittel DS, Sensen CW, Weljie AM, Vogel HJ, et al. (2011) Metabolomic response to exercise training in lean and diet-induced obese mice. J Appl Physiol 110: 1311-1318.
20. Shearer J, Duggan G, Weljie A, Hittel DS, Wasserman DH, et al. (2008) Metabolomic profiling of dietary-induced insulin resistance in the high fat-fed C57BL/6J mouse. Diabetes Obes Metab 10: 950-958.
21. Li H, Xie Z, Lin J, Song H, Wang Q, et al. (2008) Transcriptomic and metabonomic profiling of obesity-prone and obesity-resistant rats under high fat diet. J Proteome Res 7: 4775-4783.
22. Larsen FH, van den Berg F, Engelsen SB, (2006) An exploratory chemometric study of 1H NMR spectra of table wines. Journal of Chemometrics 20: 198-208.
23. Eriksson L, Johansson E, Kettaneh-Wold N, Trygg J, Wikström C, et al. (2006) Multi- and megavariate data analysis. Basic Principles and Applications.: Umetrics AB.
24. Xia J, Wishart DS, (2010) MSEA: a web-based tool to identify biologically meaningful patterns in quantitative metabolomic data. Nucleic Acids Res 38: W71-77.
25. Pelleymounter MA, Cullen MJ, Baker MB, Hecht R, Winters D, et al. (1995) Effects of the obese gene product on body weight regulation in ob/ob mice. Science 269: 540-543.
26. Golay A, Swislocki AL, Chen YD, Jaspan JB, Reaven GM, (1986) Effect of obesity on ambient plasma glucose, free fatty acid, insulin, growth hormone, and glucagon concentrations. J Clin Endocrinol Metab 63: 481-484.
27. Dakshinamurti K, Chauhan J, (1989) Biotin. Vitam Horm 45: 337-384.
28. Brosnan JT, Brosnan ME, (2010) Creatine metabolism and the urea cycle. Mol Genet Metab 100Suppl 1: S49-52.
29. Zyromski NJ, Mathur A, Gowda GA, Murphy C, Swartz-Basile DA, et al. (2009) Nuclear magnetic resonance spectroscopy-based metabolomics of the fatty pancreas: implicating fat in pancreatic pathology. Pancreatology 9: 410-419.
30. Gipson GT, Tatsuoka KS, Ball RJ, Sokhansanj BA, Hansen MK, et al. (2008) Multi-platform investigation of the metabolome in a leptin receptor defective murine model of type 2 diabetes. Mol Biosyst 4: 1015-1023.
31. Hay N, Sonenberg N, (2004) Upstream and downstream of mTOR. Genes Dev 18: 1926-1945.
32. Kimball SR, Jefferson LS, (2001) Regulation of protein synthesis by branched-chain amino acids. Curr Opin Clin Nutr Metab Care 4: 39-43.
33. Ruderman NB, (1975) Muscle amino acid metabolism and gluconeogenesis. Annu Rev Med 26: 245-258.
34. Holecek M, (2001) The BCAA-BCKA cycle: its relation to alanine and glutamine synthesis and protein balance. Nutrition 17: 70.
35. Layman DK, Walker DA, (2006) Potential importance of leucine in treatment of obesity and the metabolic syndrome. J Nutr 136: 319S-323S.
36. Lynch CJ, (2001) Role of leucine in the regulation of mTOR by amino acids: revelations from structure-activity studies. J Nutr 131: 861S-865S.
37. Calles-Escandon J, Cunningham J, Felig P, (1984) The plasma amino acid response to cafeteria feeding in the rat: influence of hyperphagia, sucrose intake, and exercise. Metabolism 33: 364-368.
38. van Doorn M, Vogels J, Tas A, van Hoogdalem EJ, Burggraaf J, et al. (2007) Evaluation of metabolite profiles as biomarkers for the pharmacological effects of thiazolidinediones in Type 2 diabetes mellitus patients and healthy volunteers. Br J Clin Pharmacol 63: 562-574.
39. Garlick PJ, (2005) The role of leucine in the regulation of protein metabolism. J Nutr 135: 1553S-1556S.
40. Xie B, Waters MJ, Schirra HJ, (2012) Investigating potential mechanisms of obesity by metabolomics. J Biomed Biotechnol 2012: 805683.
41. Sishi B, Loos B, Ellis B, Smith W, du Toit EF, et al. (2011) Diet-induced obesity alters signalling pathways and induces atrophy and apoptosis in skeletal muscle in a prediabetic rat model. Exp Physiol 96: 179-193.
42. Macotela Y, Emanuelli B, Bang AM, Espinoza DO, Boucher J, et al. (2011) Dietary leucine-an environmental modifier of insulin resistance acting on multiple levels of metabolism. PLoS One 6: e21187.
43. Hinault C, Mothe-Satney I, Gautier N, Lawrence JC Jr, Van Obberghen E, (2004) Amino acids and leucine allow insulin activation of the PKB/mTOR pathway in normal adipocytes treated with wortmannin and in adipocytes from db/db mice. FASEB J 18: 1894-1896.
44. Fu WJ, Haynes TE, Kohli R, Hu J, Shi W, et al. (2005) Dietary L-arginine supplementation reduces fat mass in Zucker diabetic fatty rats. J Nutr 135: 714-721.
45. McKnight JR, Satterfield MC, Jobgen WS, Smith SB, Spencer TE, et al. (2010) Beneficial effects of L-arginine on reducing obesity: potential mechanisms and important implications for human health. Amino Acids 39: 349-357.
46. Jobgen W, Meininger CJ, Jobgen SC, Li P, Lee MJ, et al. (2009) Dietary L-arginine supplementation reduces white fat gain and enhances skeletal muscle and brown fat masses in diet-induced obese rats. J Nutr 139: 230-237.
47. Wu G, Bazer FW, Davis TA, Kim SW, Li P, et al. (2009) Arginine metabolism and nutrition in growth, health and disease. Amino Acids 37: 153-168.
48. Oberbach A, Bluher M, Wirth H, Till H, Kovacs P, et al. (2011) Combined proteomic and metabolomic profiling of serum reveals association of the complement system with obesity and identifies novel markers of body fat mass changes. J Proteome Res 10: 4769-4788.
49. Backman L, Hallberg D, Kallner A, (1975) Amino acid pattern in plasma before and after jejuno-ileal shunt operation for obesity. Scand J Gastroenterol 10: 811-816.
50. Piloquet H, Ferchaud-Roucher V, Duengler F, Zair Y, Maugere P, et al. (2003) Insulin effects on acetate metabolism. Am J Physiol Endocrinol Metab 285: E561-565.
51. DeVilliers DC Jr, Dixit PK, Lazarow A, (1966) Citrate metabolism in diabetes. I. Plasma citrate in alloxan-diabetic rats and in clinical diabetes. Metabolism 15: 458-465.
52. Randle PJ, (1998) Regulatory interactions between lipids and carbohydrates: the glucose fatty acid cycle after 35 years. Diabetes Metab Rev 14: 263-283.
53. Cha YS, (2008) Effects of L-carnitine on obesity, diabetes, and as an ergogenic aid. Asia Pac J Clin Nutr 17Suppl 1: 306-308.
54. Kim HJ, Kim JH, Noh S, Hur HJ, Sung MJ, et al. (2011) Metabolomic analysis of livers and serum from high-fat diet induced obese mice. J Proteome Res 10: 722-731.
55. Kim JY, Park JY, Kim OY, Ham BM, Kim HJ, et al. (2010) Metabolic profiling of plasma in overweight/obese and lean men using ultra performance liquid chromatography and Q-TOF mass spectrometry (UPLC-Q-TOF MS). J Proteome Res 9: 4368-4375.
56. Walker JB, (1961) Metabolic control of creatine biosynthesis. II. Restoration of transamidinase activity following creatine repression. J Biol Chem 236: 493-498.
57. Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, et al. (2006) An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444: 1027-1031.
58. Delzenne NM, Neyrinck AM, Backhed F, Cani PD, (2011) Targeting gut microbiota in obesity: effects of prebiotics and probiotics. Nat Rev Endocrinol 7: 639-646.
59. Jung JY, Kim IY, Kim YN, Kim JS, Shin JH, et al. (2012) 1H NMR-based metabolite profiling of diet-induced obesity in a mouse mode. BMB Rep 45: 419-424.
60. Dumas ME, Barton RH, Toye A, Cloarec O, Blancher C, et al. (2006) Metabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulin-resistant mice. Proc Natl Acad Sci U S A 103: 12511-12516.
61. Koeth RA, Wang Z, Levison BS, Buffa JA, Org E, et al. (2013) Intestinal microbiota metabolism of l-carnitine, a nutrient in red meat, promotes atherosclerosis. Nat Med 19: 576-585.
62. Nicholson JK, Holmes E, Wilson ID, (2005) Gut microorganisms, mammalian metabolism and personalized health care. Nat Rev Microbiol 3: 431-438.
63. Lees HJ, Swann JR, Wilson ID, Nicholson JK, Holmes E (2013) Hippurate: The Natural History of a Mammalian-Microbial Cometabolite. J Proteome Res.
64. Williams RE, Lenz EM, Evans JA, Wilson ID, Granger JH, et al. (2005) A combined (1)H NMR and HPLC-MS-based metabonomic study of urine from obese (fa/fa) Zucker and normal Wistar-derived rats. J Pharm Biomed Anal 38: 465-471.
65. Salek RM, Maguire ML, Bentley E, Rubtsov DV, Hough T, et al. (2007) A metabolomic comparison of urinary changes in type 2 diabetes in mouse, rat, and human. Physiol Genomics 29: 99-108.
66. Calvani R, Miccheli A, Capuani G, Tomassini Miccheli A, Puccetti C, et al. (2010) Gut microbiome-derived metabolites characterize a peculiar obese urinary metabotype. Int J Obes (Lond) 34: 1095-1098.
67. Smith EA, Macfarlane GT, (1996) Enumeration of human colonic bacteria producing phenolic and indolic compounds: effects of pH, carbohydrate availability and retention time on dissimilatory aromatic amino acid metabolism. J Appl Bacteriol 81: 288-302.
68. Macfarlane GT, Gibson GR, Beatty E, Cummings JH, (1992) Estimation of short-chain fatty acid production from protein by human intestinal bacteria based on branched-chain fatty acid measurements. FEMS Microbiology Letters 101: 81-88.
69. Li M, Wang B, Zhang M, Rantalainen M, Wang S, et al. (2008) Symbiotic gut microbes modulate human metabolic phenotypes. Proc Natl Acad Sci U S A 105: 2117-2122.
70. Sun J, Schnackenberg LK, Holland RD, Schmitt TC, Cantor GH, et al. (2008) Metabonomics evaluation of urine from rats given acute and chronic doses of acetaminophen using NMR and UPLC/MS. J Chromatogr B Analyt Technol Biomed Life Sci 871: 328-340.
71. Satoh H, (1994) Cardioprotective actions of taurine against intracellular and extracellular calcium-induced effects. Adv Exp Med Biol 359: 181-196.
72. Zhang M, Bi LF, Fang JH, Su XL, Da GL, et al. (2004) Beneficial effects of taurine on serum lipids in overweight or obese non-diabetic subjects. Amino Acids 26: 267-271.
73. Kochhar S, Jacobs DM, Ramadan Z, Berruex F, Fuerholz A, et al. (2006) Probing gender-specific metabolism differences in humans by nuclear magnetic resonance-based metabonomics. Anal Biochem 352: 274-281.
74. Dey J, Creighton A, Lindberg JS, Fuselier HA, Kok DJ, et al. (2002) Estrogen replacement increased the citrate and calcium excretion rates in postmenopausal women with recurrent urolithiasis. J Urol 167: 169-171.
75. D'Eon T, Braun B, (2002) The roles of estrogen and progesterone in regulating carbohydrate and fat utilization at rest and during exercise. J Womens Health Gend Based Med 11: 225-237.
76. Laaksonen DE, Niskanen L, Punnonen K, Nyyssonen K, Tuomainen TP, et al. (2004) Testosterone and sex hormone-binding globulin predict the metabolic syndrome and diabetes in middle-aged men. Diabetes Care 27: 1036-1041.
77. Stellato RK, Feldman HA, Hamdy O, Horton ES, McKinlay JB, (2000) Testosterone, sex hormone-binding globulin, and the development of type 2 diabetes in middle-aged men: prospective results from the Massachusetts male aging study. Diabetes Care 23: 490-494.
78. Grossmann M, Thomas MC, Panagiotopoulos S, Sharpe K, Macisaac RJ, et al. (2008) Low testosterone levels are common and associated with insulin resistance in men with diabetes. J Clin Endocrinol Metab 93: 1834-1840.
79. Gale EA, Gillespie KM, (2001) Diabetes and gender. Diabetologia 44: 3-15.
80. Cao J, Chen TM, Hao WJ, Li J, Liu L, et al. (2012) Correlation between sex hormone levels and obesity in the elderly male. Aging Male 15: 85-89.
81. Plumb R, Granger J, Stumpf C, Wilson ID, Evans JA, et al. (2003) Metabonomic analysis of mouse urine by liquid-chromatography-time of flight mass spectrometry (LC-TOFMS): detection of strain, diurnal and gender differences. Analyst 128: 819-823.
82. Slupsky CM, Rankin KN, Wagner J, Fu H, Chang D, et al. (2007) Investigations of the effects of gender, diurnal variation, and age in human urinary metabolomic profiles. Anal Chem 79: 6995-7004.
83. Bae KH, Kim WK, Lee SC, (2012) Involvement of protein tyrosine phosphatases in adipogenesis: new anti-obesity targets? BMB Rep 45: 700-706.